Published in Biol Psychiatry on June 15, 2005
Brain Imaging, Attention, and Auditory Processing in Schizophrenia | NCT03068806
Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev (2010) 11.25
Population genomics in a disease targeted primary cell model. Genome Res (2009) 2.20
When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. Schizophr Bull (2009) 1.59
Functional NMDA receptors with atypical properties are expressed in podocytes. Am J Physiol Cell Physiol (2010) 1.54
Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc Natl Acad Sci U S A (2007) 1.46
Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev (2008) 1.46
Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr Res (2008) 1.29
d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia. Eur J Neurosci (2007) 1.29
Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders. Eur Arch Psychiatry Clin Neurosci (2013) 1.24
The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors. Open Med Chem J (2010) 1.21
Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Hum Mol Genet (2009) 1.18
Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion. Mol Psychiatry (2012) 1.15
The neurobiology of D-amino acid oxidase and its involvement in schizophrenia. Mol Psychiatry (2009) 1.12
Potential pathophysiological role of D-amino acid oxidase in schizophrenia: immunohistochemical and in situ hybridization study of the expression in human and rat brain. J Neural Transm (Vienna) (2009) 0.91
Neonatal disruption of serine racemase causes schizophrenia-like behavioral abnormalities in adulthood: clinical rescue by d-serine. PLoS One (2013) 0.88
Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice. Genes Brain Behav (2009) 0.85
The association of schizophrenia risk D-amino acid oxidase polymorphisms with sensorimotor gating, working memory and personality in healthy males. Neuropsychopharmacology (2011) 0.84
Serine enantiomers as diagnostic biomarkers for schizophrenia and bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2015) 0.84
Glycine and D: -serine, but not D: -cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801. Psychopharmacology (Berl) (2008) 0.83
D-serine signalling as a prominent determinant of neuronal-glial dialogue in the healthy and diseased brain. J Cell Mol Med (2008) 0.82
A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice. Transl Psychiatry (2015) 0.82
d-amino acid oxidase knockout (Dao(-/-) ) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption. Eur J Neurosci (2015) 0.79
Serum glutamine, set-shifting ability and anorexia nervosa. Ann Gen Psychiatry (2010) 0.78
A novel balanced chromosomal translocation found in subjects with schizophrenia and schizotypal personality disorder: altered l-serine level associated with disruption of PSAT1 gene expression. Neurosci Res (2010) 0.78
Serine racemase: a key player in apoptosis and necrosis. Front Synaptic Neurosci (2014) 0.78
Blood D-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine. Psychopharmacology (Berl) (2014) 0.78
Supplementation with D-serine prevents the onset of cognitive deficits in adult offspring after maternal immune activation. Sci Rep (2016) 0.77
Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder. BBA Clin (2016) 0.77
D-amino acid oxidase activity is inhibited by an interaction with bassoon protein at the presynaptic active zone. J Biol Chem (2011) 0.77
Early Intervention for Psychosis with N-Methyl-D-Aspartate Receptor Modulators. Clin Psychopharmacol Neurosci (2015) 0.76
D-Serine and Serine Racemase Are Associated with PSD-95 and Glutamatergic Synapse Stability. Front Cell Neurosci (2016) 0.75
Clinical and biochemical study of d-serine metabolism among schizophrenia patients. Neuropsychiatr Dis Treat (2017) 0.75
Spatiotemporal localization of D-amino acid oxidase and D-aspartate oxidases during development in Caenorhabditis elegans. Mol Cell Biol (2012) 0.75
Impact of plasma transaminase levels on the peripheral blood glutamate levels and memory functions in healthy subjects. BBA Clin (2016) 0.75
Decreased free d-aspartate levels are linked to enhanced d-aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients. NPJ Schizophr (2017) 0.75
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol (2009) 21.94
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet (2009) 8.11
Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry (2003) 3.12
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02
Calcium signals: the lead currency of plant information processing. Plant Cell (2010) 2.87
Oral care reduces pneumonia in older patients in nursing homes. J Am Geriatr Soc (2002) 2.68
Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients. J Clin Invest (2007) 2.45
Multicolor bimolecular fluorescence complementation reveals simultaneous formation of alternative CBL/CIPK complexes in planta. Plant J (2008) 2.44
Increased serum levels of glutamate in adult patients with autism. Prog Neuropsychopharmacol Biol Psychiatry (2006) 2.42
Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines. Clin Cancer Res (2007) 2.31
Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol (2010) 2.18
Ifenprodil for the treatment of flashbacks in female posttraumatic stress disorder patients with a history of childhood sexual abuse. Biol Psychiatry (2011) 2.16
Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet (2004) 2.13
Frequent EGFR mutations in brain metastases of lung adenocarcinoma. Int J Cancer (2006) 2.11
Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry (2007) 2.05
Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci (2008) 1.96
Inducible protein knockout reveals temporal requirement of CaMKII reactivation for memory consolidation in the brain. Proc Natl Acad Sci U S A (2003) 1.93
Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry (2003) 1.93
Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry (2006) 1.93
Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. PLoS Biol (2007) 1.88
Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry (2005) 1.85
Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev (2004) 1.82
SMG-8 and SMG-9, two novel subunits of the SMG-1 complex, regulate remodeling of the mRNA surveillance complex during nonsense-mediated mRNA decay. Genes Dev (2009) 1.82
A ubiquitin-10 promoter-based vector set for fluorescent protein tagging facilitates temporal stability and native protein distribution in transient and stable expression studies. Plant J (2010) 1.75
Prospective randomized trial of transnasal versus peroral endoscopy using an ultrathin videoendoscope in unsedated patients. J Gastroenterol Hepatol (2007) 1.74
Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch Gen Psychiatry (2008) 1.72
Approximate entropy of human respiratory movement during eye-closed waking and different sleep stages. Chest (2003) 1.72
Measurement of Pseudomonas aeruginosa multidrug efflux pumps by quantitative real-time polymerase chain reaction. FEMS Microbiol Lett (2005) 1.63
Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease. J Nucl Med (2013) 1.58
Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry (2013) 1.57
Prospective comparative study on the acceptability of unsedated transnasal endoscopy in younger versus older patients. J Clin Gastroenterol (2008) 1.54
Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry (2010) 1.53
All-trans retinoic acid and a novel synthetic retinoid tamibarotene (Am80) differentially regulate CD38 expression in human leukemia HL-60 cells: possible involvement of protein kinase C-delta. J Leukoc Biol (2011) 1.50
DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci (2005) 1.49
Microglial activation in schizophrenia and minocycline treatment. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.47
Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc Natl Acad Sci U S A (2007) 1.46
Effectiveness of Information Technology Aided Relapse Prevention Programme in Schizophrenia excluding the effect of user adherence: a randomized controlled trial. Schizophr Res (2013) 1.45
fMRI study of recognition of facial expressions in high-functioning autistic patients. Neuroreport (2003) 1.44
Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry (2003) 1.41
Childhood-onset schizophrenia and tryptophan hydroxylase gene polymorphism. Am J Med Genet B Neuropsychiatr Genet (2004) 1.40
Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. Am J Psychiatry (2012) 1.40
Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol (2014) 1.39
Zonisamide-induced depression and mania in patients with epilepsy. J Clin Psychopharmacol (2004) 1.38
Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS One (2012) 1.36
Two genetic variants of CD38 in subjects with autism spectrum disorder and controls. Neurosci Res (2010) 1.35
High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503. Biol Psychiatry (2007) 1.33
Developmental changes in KCC1, KCC2, and NKCC1 mRNA expressions in the rat brain. Brain Res Dev Brain Res (2002) 1.32
An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis. Dig Dis Sci (2006) 1.30
Correlation between Asian dust storms and worsening asthma in Western Japan. Allergol Int (2011) 1.30
Synthesis and biological evaluation of D-amino acid oxidase inhibitors. J Med Chem (2008) 1.29
Adult case of an omphalomesenteric cyst resected by laparoscopic-assisted surgery. World J Gastroenterol (2006) 1.28
NMDA- and beta-amyloid1-42-induced neurotoxicity is attenuated in serine racemase knock-out mice. J Neurosci (2008) 1.27
Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine. Biol Psychiatry (2009) 1.27
Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.24
Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways. PLoS One (2008) 1.24
Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One (2011) 1.24
Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.23